Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101
MONTREAL, Oct. 21, 2024 /PRNewswire/ - Find Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced initiation of dosing in its


